Abstract
We have previously shown that human colon carcinoma CaCo-2 cells express the Sda-β1,4-N-acetylgalactosaminyltransferase (Sda-βGalNAc-transferase) and that the enzyme activity correlates with the degree of enterocytic differentiation. Here we report that a large amount of this glycosyltransferase is released in soluble form, particularly when CaCo-2 cells are maintained in culture for more than 3 weeks in order to ensure an higher degree of enterocyte differentiation. The soluble enzyme was concentrated and partially purified by Blue-Sepharose and fetuin-Sepharose chromatography. The substrate specificity of the partially purified enzyme was similar to that of Sda-enzyme from epithelial cells of colon mucosa, and for its activity strictly required the presence in acceptors of NeuAc in α2,3-linkage to subterminal galactose. Among the low molecular glycans tested, NeuAcα2,3Galβ1,4GlcNAc appeared to be the best acceptor, whereas sialyl-Lewisx and sialyl-Lewisa did not serve as acceptors, indicating that the fucosylation of sub-terminal GlcNAc hindered the transferase activity. Contrary to this, the activity towards a disialylated acceptor such as di-sialyl-lacto-N-tetraose was reduced but not abolished. When CaCo-2 cells were cultured on porous membranes and the transferase activity assayed in medium collected from chambers corresponding to either the apical or basolateral face of highly differentiated CaCo-2 cells, a preferential release from the basolateral surface was found. Considering that Sda-βGalNAc-transferase is mainly located in the large intestine, current results support the notion that colonic cells largely contribute to the presence of the enzyme in human plasma.
Similar content being viewed by others
References
Serafini-Cessi F, Dall'Olio F (1983)Biochem J 215: 483–89.
Serafini-Cessi F, Dall'Olio F, Malagolini N (1986)Carbohydr Res 151: 65–76.
Donald ASR, Soh CPC, Yates AD, Feeney J, Morgan WTJ, Watkins WM (1987)Biochem Soc Trans 15: 606–8.
Serafini-Cessi F, Malagolini N, Dall'Olio F (1988)Arch Biochem Biophys 266: 573–82.
Donald ASR, Yates AD, Soh CPC, Morgan WTJ, Watkins WM (1983)Biochem Biophys Res Commun 115: 625–31.
Piller F, Blanchard D, Huet M, Cartron J-P (1986)Carbohydr Res 149: 171–84.
Malagolini N, Dall'Olio F, Di Stefano G, Minni F, Marrano D, Serafini-Cessi F (1989)Cancer Res 49: 6466–70.
Morton JA, Pickles MM, Vanhegan RI (1988)Immunol Invest 17: 217–24.
Dall'Olio F, Malagolini N, Serafini-Cessi F (1987)Biosci Rep 7: 925–32.
Conzelmann A, Brow C (1987)Biochem J 242: 817–24.
Dall'Olio F, Malagolini N, Di Stefano G, Ciambella M, Serafini-Cessi F (1990)Biochem J 270: 519–25.
Malagolini N, Dall'Olio F, Guerrini S, Serafini-Cessi F (1994)Glycoconjugate J 11: 89–95.
Takeya A, Hosomi O, Kogure T (1987)J Biochem 101: 251–59.
Malagolini N, Dall'Olio F, Serafini-Cessi F (1991)Biochem Biophys Res Commun 180: 681–86.
Pinto M, Robine-Leon S, Appay MD, Kedinger M, Triadou N, Dassaulx E, Lacroix B, Simmon-Assman P, Haffen K, Fogh J, Zweibaum A (1983)Biol Cell 47: 323–30.
Zweibaum A, Triadou N, Kedinger M, Augeron C, Robine-Leon S, Pinto M, Rousset M, Haffen K (1983)Int J Cancer 32: 407–12.
Conzelmann A, Kornfeld S (1984)J Biol Chem 259: 12536–42.
Smith PL, Lowe JB (1994)J Biol Chem 269: 15163–15171.
Vachon PH, Beaulieu JF (1992)Gastroenterology 103: 414–23.
Serafini-Cessi F, Malagolini N, Dall'Olio F, Pereira L, Campadelli-Fiume G (1985)Arch Biochem Biophys 240: 866–76.
Paulson JC, Weinstein J, Dornland L, van Halbeck H, Vliegenthart JFG (1982)J Biol Chem 257: 12734–38.
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951)J Biol Chem 193: 265–75.
Dahlqvist A (1968)Anal Biochem 22: 99–107.
Dall'Olio F, Malagolini N, Serafini-Cessi F (1992)Biochem Biophys Res Commun 184: 1405–10.
Takeya A, Hosomi O, Ishiura M (1990)J Biochem 107: 360–68.
Klumperman J, Fransen JAM, Boekestijn TC, Oude Elferink RPJ, Matter K, Haur H-P, Tager JM, Ginsel LA (1991)J Cell Sci 100: 339–47.
Rindler MJ, Traber MG (1988)J Cell Biol 107: 471–79.
Low GM, Futerman AH, Ackermann KE, Sherman WR, Silman I (1987)Biochem J 241: 615–19.
Le Bivic A, Quaroni A, Nichols B, Rodrigez-Boulan E (1990)J Cell Biol 111: 1351–61.
Weinstein J, Lee EJ, McEntee K, Lai P-H, Paulson J (1987)J Biol Chem 262: 17735–43.
Soh CPC, Donald ASR, Feeney J, Morgan WTJ, Watkins WM (1989)Glycoconjugate J 6: 319–32.
Yago K, Zenita KZ, Ginya H, Sawada M, Ohmori K, Okuma M, Kannagi R, Lowe JB (1993)Cancer Res 53: 5559–65.
Matsushita Y, Nakamori S, Seftro EA, Hendrix MJC, Irimura T (1991)Exp Cell Res 197: 20–25.
Nakamori S, Kameyama M, Imaoka S, Furukawa H, Ishikawa O, Sasaki Y, Kabuto T, Iwanaga T, Matsushita Y, Irimura T (1993)Cancer Res 53: 3632–37.
Dall'Olio F, Malagolini N, Di Stefano G, Minni F, Marrano D, Serafini-Cessi F (1989)Int J Cancer 44: 434–39.
Harder PG, Jamieson JC, Woloski BMRNJ (1990)Int J Biochem 22: 11–14.
Jamieson JC, McCaffrey G, Hardes PG (1993)Comp Biochem Physiol 105B: 29–33.
Molmenti EP, Ziambaras T, Pelmutter DH (1993)J Biol Chem 268: 14116–24.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Serafini-Cessi, F., Malagolini, N., Guerrini, S. et al. A soluble form of Sda-β1,4-N-acetylgalactosaminyltransferase is released by differentiated human colon carcinoma CaCo-2 cells. Glycoconjugate J 12, 773–779 (1995). https://doi.org/10.1007/BF00731238
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00731238